Skip to main content
. 2020 May 14;10:7946. doi: 10.1038/s41598-020-64794-8

Table 2.

Clinicopathological features for the patient cohort (n = 96).

Number of patients (%) P value
CCC (n = 17) EC (n = 17) HGSC (n = 51) MC (n = 11)
Patient age 0.95
Mean 63 64 63 61
Range 42–84 25–83 32–86 39–80
Overall Survival 0.45
0–2 y 2 (12) 1 (6) 2 (4) 3 (27)
2–5 y 3 (18) 5 (29) 17 (33) 2 (18)
5–10 y 7 (41) 5 (29) 19 (37) 3 (27)
>10 y 5 (29) 6 (35) 13 (25) 3 (27)
Cause of death 0.01
Ovarian carcinoma 10 (59) 3 (18) 33 (65) 2 (18)
Other cancer 0 (0) 3 (18) 7 (14) 3 (27)
Other 6 (35) 6 (35) 5 (10) 4 (36)
Not available 1 (6) 0 (0) 0 (0) 0 (0)
Alive 0 (0) 5 (29) 6 (12) 2 (18)
Stage 0.15
I 14 (82) 11 (65) 29 (57) 9 (82)
II 3 (18) 6 (35) 22 (43) 2 (18)
Tumor grade EC NA
FIGO grade I NA 2 (12) NA NA
FIGO grade II NA 9 (53) NA NA
FIGO grade III NA 6 (35) NA NA
CA125 0.068
<35 6 (35) 7 (41) 9 (18) 5 (45)
35–65 1 (6) 0 (0) 29 (57) 2 (18)
>65 10 (59) 10 (59) 13 (25) 4 (36)
Not available 0 (0) 0 (0) 0 (0) 0 (0)
Ploidy 0.095
Near diploid 1 (6) 7 (41) 15 (29) 2 (18)
Aneuploid 16 (94) 9 (53) 36 (71) 8 (73)
Not available 0 (0) 1 (6) 0 (0) 1 (9)
Chemotherapy NA
Yes 17 (100) 17 (100) 49 (96) 11 (100)
No 0 (0) 0 (0) 0 (0) 0 (0)
Not available 0 (0) 0 (0) 2 (4) 0 (0)

Significant values (P value<0.05) are marked in bold.